The Week Ahead: Ocado, AstraZeneca, RELX
Our head of markets rounds up the week and names the big events to watch closely in the days ahead.
5th February 2021 14:20
by Richard Hunter from interactive investor
As earnings season rumbles on, our head of markets rounds up the week and names the company results and big events to watch closely in the days ahead.
Results are coming thick and fast in the US, so visit our suite of useful content to navigate the Q4 earnings season.
- Find out which big US companies are reporting and when by opening our new calendar
- What is earnings season?
- Want to buy and sell US shares? It’s easy to do. Here’s how
- Investing in the US stock market: a beginner’s guide
Monday 8 February
Trading statements
Electrocomponents, Inland Homes, UP Global Sourcing
AGM/EGM
Blue Star Capital, Schroder UK Mid Cap Fund, Actual Experience
Tuesday 9 February
Trading statements
Amino Technologies, Bellway, DFS Furniture, Discoverie Group, Mattioli Woods, Micro Focus International, Ocado Group (LSE:OCDO), RM, St Modwen Properties, Tui AG
AGM/EGM
Benchmark Holdings, Numis, Tritax EuroBox
Wednesday 10 February
Trading statements
Redrow, Smurfit Kappa, Avingtrans, RWS Holdings, Grainger, Ashmore Group, Dunelm, Lancashire Holdings
AGM/EGM
Keystone Investment Trust, Ramsdens, Tharisa, GCP Infrastructure Investments, Grainger, RWS Holdings, Hibernia REIT, Mothercare
Thursday 11 February
Companies scheduled to begin trading without the right to the latest dividend include PZ Cussons and Avon Rubber.
Trading statements
Ted Baker, Coca-Cola HBC, S&U, RELX (LSE:REL), MJ Gleeson, Coca-Cola European Partners, AstraZeneca (LSE:AZN)
AGM/EGM
Euromoney Institutional Investor, Tesco, Calisen
Friday 12 February
Trading statements
Vistry, Victrex
AGM/EGM
Irish Continental Group, Mincon, FBD Holdings, Remote Monitored Systems
These articles are provided for information purposes only. Occasionally, an opinion about whether to buy or sell a specific investment may be provided by third parties. The content is not intended to be a personal recommendation to buy or sell any financial instrument or product, or to adopt any investment strategy as it is not provided based on an assessment of your investing knowledge and experience, your financial situation or your investment objectives. The value of your investments, and the income derived from them, may go down as well as up. You may not get back all the money that you invest. The investments referred to in this article may not be suitable for all investors, and if in doubt, an investor should seek advice from a qualified investment adviser.
Full performance can be found on the company or index summary page on the interactive investor website. Simply click on the company's or index name highlighted in the article.